Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey.
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey.
复制标题
DOI：
10.1097/adm.0000000000000746
复制
发表时间：
2020-12
影响因子：
5.5
通讯作者：
Fiellin DA
中科院分区：
文献类型：
--
作者：
Cone DC;Bogucki S;Burns K;D'Onofrio G;Hawk K;Joseph D;Fiellin DA
美国新冠肺炎 (COVID-19) 疫情正值阿片类药物过量危机爆发。由于担心新型冠状病毒感染，紧急医疗服务 (EMS) 临床医生可能会限制鼻内纳洛酮的使用。我们试图确定 EMS 临床医生用药过量事件和纳洛酮给药实践的变化。 2020 年 4 月 29 日至 2020 年 5 月 15 日期间，我们对美国各地的 EMS 奖学金计划负责人进行了调查，了解自 2020 年 3 月以来其服务区的用药过量事件和纳洛酮管理实践发生了怎样的变化。基于全国所有地区的 60 名受访者，五分之一的受访社区经历了阿片类药物过量和纳洛酮管理事件的增加，40% 的社区出现了减少。调查结果因国家地区而异。 18% 的受访者不鼓励或禁止使用鼻内纳洛酮，10% 的受访者鼓励使用肌肉注射纳洛酮。这些发现可能有助于了解这段时间内阿片类药物过量死亡率的变化，并有助于未来的灾难规划。
The COVID-19 epidemic in the United States has hit in the midst of the opioid overdose crisis. Emergency medical services (EMS) clinicians may limit their use of intranasal naloxone due to concerns of novel coronavirus infection. We sought to determine changes in overdose events and naloxone administration practices by EMS clinicians. Between April 29, 2020 and May 15, 2020, we surveyed directors of EMS fellowship programs across the US about how overdose events and naloxone administration practices had changed in their catchment areas since March 2020. Based on 60 respondents across all regions of the country, one fifth of surveyed communities have experienced an increase in opioid overdoses and events during which naloxone was administered, and 40% have experienced a decrease. The findings varied by region of the country. Eighteen percent of respondents have discouraged or prohibited the use of intranasal naloxone with 10% encouraging the use of intramuscular naloxone. These findings may provide insight into changes in opioid overdose mortality during this time and assist in future disaster planning.